94 related articles for article (PubMed ID: 30420336)
1. Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model.
Amigoni L; Airoldi C; Natalello A; Romeo M; Diomede L; Tortora P; Regonesi ME
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):279-290. PubMed ID: 30420336
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.
Bonanomi M; Natalello A; Visentin C; Pastori V; Penco A; Cornelli G; Colombo G; Malabarba MG; Doglia SM; Relini A; Regonesi ME; Tortora P
Hum Mol Genet; 2014 Dec; 23(24):6542-52. PubMed ID: 25030034
[TBL] [Abstract][Full Text] [Related]
3. How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode.
Bonanomi M; Visentin C; Natalello A; Spinelli M; Vanoni M; Airoldi C; Regonesi ME; Tortora P
Chemistry; 2015 Dec; 21(50):18383-93. PubMed ID: 26538519
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model.
Visentin C; Pellistri F; Natalello A; Vertemara J; Bonanomi M; Gatta E; Penco A; Relini A; De Gioia L; Airoldi C; Regonesi ME; Tortora P
Hum Mol Genet; 2017 Sep; 26(17):3271-3284. PubMed ID: 28633380
[TBL] [Abstract][Full Text] [Related]
5. Protein Environment: A Crucial Triggering Factor in Josephin Domain Aggregation: The Role of 2,2,2-Trifluoroethanol.
Visentin C; Navarro S; Grasso G; Regonesi ME; Deriu MA; Tortora P; Ventura S
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042316
[TBL] [Abstract][Full Text] [Related]
6. Rescue of ATXN3 neuronal toxicity in
Fardghassemi Y; Tauffenberger A; Gosselin S; Parker JA
Dis Model Mech; 2017 Dec; 10(12):1465-1480. PubMed ID: 29061563
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free and In Vivo Characterization of the Inhibitory Activity of
Sciandrone B; Palmioli A; Ciaramelli C; Pensotti R; Colombo L; Regonesi ME; Airoldi C
ACS Chem Neurosci; 2024 Jan; 15(2):278-289. PubMed ID: 38154144
[TBL] [Abstract][Full Text] [Related]
8. Infrared nanospectroscopy characterization of oligomeric and fibrillar aggregates during amyloid formation.
Ruggeri FS; Longo G; Faggiano S; Lipiec E; Pastore A; Dietler G
Nat Commun; 2015 Jul; 6():7831. PubMed ID: 26215704
[TBL] [Abstract][Full Text] [Related]
9. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Ataxin-3 and Ataxin-7 aggregates formed in vivo in Drosophila reveals a threshold of aggregated polyglutamine proteins associated with cellular toxicity.
Vinatier G; Corsi JM; Mignotte B; Gaumer S
Biochem Biophys Res Commun; 2015 Sep; 464(4):1060-1065. PubMed ID: 26210447
[TBL] [Abstract][Full Text] [Related]
11. Phytochemicals-induced hormesis protects Caenorhabditis elegans against α-synuclein protein aggregation and stress through modulating HSF-1 and SKN-1/Nrf2 signaling pathways.
Govindan S; Amirthalingam M; Duraisamy K; Govindhan T; Sundararaj N; Palanisamy S
Biomed Pharmacother; 2018 Jun; 102():812-822. PubMed ID: 29605769
[TBL] [Abstract][Full Text] [Related]
12. Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3.
Rodrigues AJ; Coppola G; Santos C; Costa Mdo C; Ailion M; Sequeiros J; Geschwind DH; Maciel P
FASEB J; 2007 Apr; 21(4):1126-36. PubMed ID: 17234717
[TBL] [Abstract][Full Text] [Related]
13. Delaying aging in Caenorhabditis elegans with protein aggregation inhibitors.
Cuanalo-Contreras K; Park KW; Mukherjee A; Millán-Pérez Peña L; Soto C
Biochem Biophys Res Commun; 2017 Jan; 482(1):62-67. PubMed ID: 27810360
[TBL] [Abstract][Full Text] [Related]
14. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS
Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
[TBL] [Abstract][Full Text] [Related]
16. Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment.
Pir GJ; Choudhary B; Kaniyappan S; Chandupatla RR; Mandelkow E; Mandelkow EM; Wang Y
Mol Neurobiol; 2019 May; 56(5):3751-3767. PubMed ID: 30196394
[TBL] [Abstract][Full Text] [Related]
17. In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model.
Van Assche R; Borghgraef C; Vaneyck J; Dumoulin M; Schoofs L; Temmerman L
J Negat Results Biomed; 2017 Aug; 16(1):14. PubMed ID: 28830560
[TBL] [Abstract][Full Text] [Related]
18. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
[TBL] [Abstract][Full Text] [Related]
19. Effects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a
Gamir-Morralla A; Sacristán S; Medina M; Iglesias T
J Alzheimers Dis Rep; 2019 Feb; 3(1):47-57. PubMed ID: 30842997
[TBL] [Abstract][Full Text] [Related]
20. Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment.
Rosas PC; Nagaraja GM; Kaur P; Panossian A; Wickman G; Garcia LR; Al-Khamis FA; Asea AA
PLoS One; 2016; 11(3):e0149409. PubMed ID: 26960140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
